Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T19:23:21.228Z.
Calculation as of: 2026-10-06T19:23:21.228Z.
Quote observation: 2026-10-06T19:19:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4553d85706fed5bac33927ddb0c45062b9ca990621471d16f8faa1ad8920ffc8
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$160.08M
Price/OCF Ratio
N/A
TTM Avg
78.89
3Y Avg
78.89
5Y Avg
78.89
Market Cap
$162.23M
Price/OCF Ratio
N/A
TTM Avg
193.13
3Y Avg
193.13
5Y Avg
37.46
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $159.44M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | N/A | 109.43 | 140.00 | 140.00 |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.08M | N/A | 78.89 | 78.89 | 78.89 |
| Inogen, Inc. (INGN)vs › | $156.88M | N/A | 113.17 | 139.63 | 64.33 |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | N/A | 193.13 | 193.13 | 37.46 |
| Quanterix Corporation (QTRX)vs › | $162.58M | N/A | N/A | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $154.14M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $165.13M | 8.96 | 14.06 | 42.13 | 40.06 |
| Nkarta, Inc. (NKTX)vs › | $165.63M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
